Malgorzata Haduch-Domagala

Krakow, MA, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Selected Chemokines as Prognostic Biomarkers and Therapeutic Targets in Ovarian Cancer.

Selected Chemokines as Prognostic Biomarkers and Therapeutic Targets in Ovarian Cancer.

Journal: Current issues in molecular biology

Published: May 06, 2026

Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Literature Overview.

Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Literature Overview.

Journal: Cancers

Published: April 12, 2026

Current Systemic Treatment Options for Advanced Pancreatic Cancer-An Overview Article.

Current Systemic Treatment Options for Advanced Pancreatic Cancer-An Overview Article.

Journal: Biomedicines

Published: December 08, 2025

The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment-Literature Review.

The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment-Literature Review.

Journal: Biomedicines

Published: September 15, 2024

Radiochemotherapy in Pancreatic Cancer.

Radiochemotherapy in Pancreatic Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: April 29, 2024

Multimodal treatment for long-term survival in ampullary adenocarcinoma metastatic to the liver.

Multimodal treatment for long-term survival in ampullary adenocarcinoma metastatic to the liver.

Journal: Przeglad gastroenterologiczny

Published: April 24, 2024

Analysis of the efficacy and tolerability of FOLFIRINOX chemotherapy treatment in patients over 65 years of age with diagnosis of advanced adenocarcinoma of the pancreas.

Analysis of the efficacy and tolerability of FOLFIRINOX chemotherapy treatment in patients over 65 years of age with diagnosis of advanced adenocarcinoma of the pancreas.

Journal: Contemporary oncology (Poznan, Poland)

Published: November 20, 2022

Real-world treatment practice in patients with advanced melanoma.

Real-world treatment practice in patients with advanced melanoma.

Journal: Contemporary oncology (Poznan, Poland)

Published: April 04, 2020

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy.

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy.

Journal: Contemporary oncology (Poznan, Poland)

Published: February 22, 2020

Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment.

Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment.

Journal: OncoTargets and therapy

Published: August 21, 2018

Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.

Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.

Journal: American journal of translational research

Published: July 08, 2016

Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting.

Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting.

Journal: Journal of Cancer

Published: May 20, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026